Concepedia

Michael J. Mauro

MJ

Statistics

Publications

109

Citations

8.3K

H-Index

43

Active since

2000

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

The University of Texas MD Anderson Cancer Center

Jena University Hospital

Oregon Health & Science University

Hôpital Saint-Louis

Michael J. Mauro is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, chronic myeloid leukemia therapy, and pharmacology.

Publications per year

2000–2025

109

Publications

109

Ponatinib in Refractory Philadelphia Chromosome–Positive Leukemias

Jörge E. Cortes, Hagop M. Kantarjian, Neil P. Shah et al. · New England Journal of Medicine · 2012 · 770 citations · Full text

Medicine, Oncology, Pharmacology +13

Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society

Alexander R. Lyon, Susan Dent, Susannah Stanway et al. · European Journal of Heart Failure · 2020 · 770 citations · Full text

Medicine, Cardiology, Oncology +16

Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial

Jörge E. Cortes, Carlo Gambacorti‐Passerini, Michael W. Deininger et al. · Journal of Clinical Oncology · 2017 · 493 citations · Full text

Medicine, Hematology, Pharmacotherapy +12

Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis

Jason Gotlib, Hanneke C. Kluin‐Nelemans, Tracy I. George et al. · New England Journal of Medicine · 2016 · 478 citations · Full text

Medicine, Hematology, Pharmacology +16

Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure

Timothy P. Hughes, Michael J. Mauro, Jörge E. Cortes et al. · New England Journal of Medicine · 2019 · 467 citations · Full text

Medicine, Oncology, Pharmacology +9

1–5 of 109